
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SH2-B CRISPR/Cas9 KO Plasmid (m) | sc-422909 | 20 µg | $397.00 |
Mouse Sh2b1 encodes the adaptor protein SH2-B, a cytoplasmic signaling scaffold that couples activated receptor tyrosine kinases and cytokine receptors to downstream pathways such as JAK/STAT, PI3K–AKT, and MAPK. Through its SH2 domain and protein–protein interaction motifs, SH2-B modulates signal amplitude and duration to influence cellular proliferation, differentiation, and metabolic regulation. Sh2b1-dependent signaling is widely studied in the context of energy homeostasis and insulin/leptin-responsive networks, and altered SH2B1 function has been linked to phenotypes involving metabolic dysregulation and neuroendocrine control. In immune and neuronal systems, SH2-B also contributes to receptor-mediated signaling events that shape inflammatory responses and synaptic/neurite-associated processes.
SH2-B CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Sh2b1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Sh2b1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Sh2b1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SH2-B protein expression.
This CRISPR knockout system enables efficient generation of Sh2b1-deficient cell models for investigation of SH2-B signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.